Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 25.70
+2.30 (9.83%)
Sep 5, 2025, 1:23 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 5.73 billion as of September 5, 2025. Its market cap has decreased by -5.86% in one year.
Market Cap
5.73B
Enterprise Value
5.95B
Revenue
1.26B
Ranking
n/a
PE Ratio
71.60
Stock Price
25.70
Market Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 5.73B, an increase of 39.26%. That is a compound annual growth rate of 2.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 5.73B | -28.61% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | 2.72B | 20.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 394.73B |
| PharmaEssentia | 171.63B |
| Bora Pharmaceuticals Co., LTD. | 91.84B |
| Lotus Pharmaceutical | 50.76B |
| Lumosa Therapeutics | 40.43B |
| Oneness Biotech | 36.35B |
| Center Laboratories | 29.56B |
| Polaris Group | 29.31B |